Literature DB >> 24642860

Self-reported skin morbidities and health-related quality of life: a population-based nested case-control study.

G R Vinding1, K M Knudsen, C Ellervik, A B Olesen, G B E Jemec.   

Abstract

BACKGROUND: Impaired dermatological health-related quality of life (HRQoL) has been observed in hospital-based studies, but little is known on a population-based level.
OBJECTIVE: To investigate self-reported dermatological HRQoL in the general population.
METHODS: Hidradenitis suppurativa, psoriasis, pimples, hand rash or atopic eczema were identified using questionnaires in a 15,177 person population sample. A nested case-control study of 180 cases and 259 controls was made using the Dermatology Life Quality Index (DLQI), Skindex-29 and EQ-5D.
RESULTS: Cases had higher scores in DLQI and Skindex-29 and a lower score in EQ-5D, suggesting lower HRQoL. Adjusting for age and sex, the differences in Skindex-29 and DLQI were significant (p < 0.001).
CONCLUSIONS: Persons with self-reported skin morbidity had lower HRQoL than the general population. The impairment is not as significant as in studies of hospital-based cases, but considering the high prevalence of skin diseases it may still represent a significant burden of disease on society in aggregate.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 24642860     DOI: 10.1159/000358009

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  9 in total

1.  Nicastrin haploinsufficiency alters expression of type I interferon-stimulated genes: the relationship to familial hidradenitis suppurativa.

Authors:  L Cao; D J Morales-Heil; E D O Roberson
Journal:  Clin Exp Dermatol       Date:  2019-01-17       Impact factor: 3.470

Review 2.  Pain, Psychological Comorbidities, Disability, and Impaired Quality of Life in Hidradenitis Suppurativa [corrected].

Authors:  Zarine S Patel; Lauren K Hoffman; Dawn C Buse; Amy S Grinberg; Ladan Afifi; Steven R Cohen; Michelle A Lowes; Elizabeth K Seng
Journal:  Curr Pain Headache Rep       Date:  2017-11-01

Review 3.  The prediction and monitoring of toxicity associated with long-term systemic glucocorticoid therapy.

Authors:  Emma Harris; Ana Tiganescu; Sandy Tubeuf; Sarah Louise Mackie
Journal:  Curr Rheumatol Rep       Date:  2015-06       Impact factor: 4.592

4.  Psychosocial Aspects of Adult Acne: Data from 13 European Countries.

Authors:  Ilknur K Altunay; Ezgi Özkur; Florence J Dalgard; Uwe Gieler; Lucía Tomas Aragones; Lars Lien; Françoise Poot; Gregor B Jemec; Laurent Misery; Csanád Szabó; Dennis Linder; Francesca Sampogna; Andrea W M Evers; Jon Anders Halvorsen; Flora Balieva; Jacek C Szepietowski; Dmitry V Romanov; Servando E Marron; Andrew Y Finlay; Sam Salek; Jörg Kupfer
Journal:  Acta Derm Venereol       Date:  2020-02-05       Impact factor: 3.875

5.  An assessment of the relative impact of hidradenitis suppurativa, psoriasis, and obesity on quality of life.

Authors:  M A Storer; M J Danesh; M E Sandhu; V Pascoe; A B Kimball
Journal:  Int J Womens Dermatol       Date:  2018-10-11

Review 6.  Understanding economic evidence for the prevention and treatment of atopic eczema.

Authors:  T H Sach; E McManus; N J Levell
Journal:  Br J Dermatol       Date:  2019-04-11       Impact factor: 9.302

Review 7.  An Update on Health-Related Quality of Life and Patient-Reported Outcomes in Hidradenitis Suppurativa.

Authors:  J Mac Mahon; S Kirthi; N Byrne; C O'Grady; A M Tobin
Journal:  Patient Relat Outcome Meas       Date:  2020-02-10

8.  The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa.

Authors:  Alex Bató; Valentin Brodszky; L Hunor Gergely; Krisztián Gáspár; Norbert Wikonkál; Ágnes Kinyó; Ákos Szabó; Zsuzsanna Beretzky; Andrea Szegedi; Éva Remenyik; Norbert Kiss; Miklós Sárdy; Fanni Rencz
Journal:  Qual Life Res       Date:  2021-02-03       Impact factor: 4.147

9.  Highlights of the updated Dutch evidence- and consensus-based guideline on psoriasis 2017.

Authors:  G E van der Kraaij; D M W Balak; C I Busard; O D van Cranenburgh; Y Chung; R J B Driessen; M de Groot; E M G J de Jong; P M J H Kemperman; W J A de Kort; S A Karsch; A Lamberts; L L A Lecluse; P P M van Lümig; S P Menting; E P Prens; J M P A van den Reek; M M B Seyger; H B Thio; W R Veldkamp; M Wakkee; A Nast; A Jacobs; S Rosumeck; P I Spuls Chair
Journal:  Br J Dermatol       Date:  2019-01       Impact factor: 9.302

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.